UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy

Annals of oncology, 2013-06, Vol.24 (6), p.1466-1472

2013

Volltextzugriff (PDF)

Sexuality and body image in long-term survivors of testicular cancer

European journal of cancer (1990), 2012-03, Vol.48 (4), p.571-578

2012

Volltextzugriff (PDF)

Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma

British journal of cancer, 2010-03, Vol.102 (5), p.867-872

2010

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3068-3077

2000

Volltextzugriff (PDF)

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

European journal of cancer (1990), 2012-09, Vol.48 (13), p.2012-2019

2012

Volltextzugriff (PDF)

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

British journal of cancer, 2005-08, Vol.93 (3), p.273-278

2005

Volltextzugriff (PDF)

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

The Lancet (British edition), 2005-07, Vol.366 (9482), p.293-300

2005

Volltextzugriff (PDF)

Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy – results of an exploratory phase I study

Investigational new drugs, 2018-08, Vol.36 (4), p.615-618

2018

Volltextzugriff (PDF)

Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease

British journal of cancer, 2003-03, Vol.88 (5), p.658-665

2003

Volltextzugriff (PDF)

Chemotherapy-Induced Nausea, Vomiting, and Fatigue – the Role of Individual Differences Related to Sensory Perception and Autonomic Reactivity

Psychotherapy and psychosomatics, 2007-01, Vol.76 (6), p.376-384

2007

Volltextzugriff (PDF)

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

Annals of oncology, 2004-09, Vol.15 (9), p.1377-1399

2004

Volltextzugriff (PDF)

Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity

Annals of behavioral medicine, 2007-02, Vol.33 (1), p.69-79

2007

Volltextzugriff (PDF)

2599 Gemcitabine, Cisplatin, and Paclitaxel (GCT) as second-line salvage chemotherapy for germ cell tumors

European journal of cancer (1990), 2015-09, Vol.51, p.S511-S511

2015

Volltextzugriff (PDF)

Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study

Annals of oncology, 2015-04, Vol.26 (4), p.737-742

2015

Volltextzugriff (PDF)

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Annals of oncology, 2006-05, Vol.17 (suppl-5), p.v118-v122

2006

Volltextzugriff (PDF)

Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma - results from a randomised phase II trial

British journal of cancer, 2006-01, Vol.94 (2), p.218-226

2006

Volltextzugriff (PDF)

Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2006-05, Vol.24 (13), p.1997-2005

2006

Volltextzugriff (PDF)

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group

European urology, 2003-11, Vol.44 (5), p.519

2003

Volltextzugriff (PDF)

Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial

Annals of oncology, 1999-12, Vol.10 (12), p.1461-1465

1999

Volltextzugriff (PDF)

A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium

Annals of oncology, 2006-10, Vol.17 (10), p.1533-1538

2006

Volltextzugriff (PDF)

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4602-4608

2005

Volltextzugriff (PDF)

Increasing international efforts to understand and conquer testicular germ cell cancer

Andrology (Oxford), 2015-01, Vol.3 (1), p.1-3

2015

Volltextzugriff (PDF)

Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)

European journal of cancer (1990), 2020-03, Vol.127, p.173-182

2020

Volltextzugriff (PDF)

Health-related quality of life (HRQOL) in the Nordic randomized trial of adjuvant intermediate-dose interferon alfa-2b in high-risk melanoma

JOURNAL OF CLINICAL ONCOLOGY, 2011, Vol.29 (15_suppl), p.8547-8547

2011

Volltextzugriff (PDF)

Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma

British journal of cancer, 2005-10, Vol.93 (7), p.757-762

2005

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(166)
Male
(136)
Life Sciences & Biomedicine
(134)
Science & Technology
(134)
Oncology
(105)
Biological And Medical Sciences
(95)
Middle Aged
(95)
Medical Sciences
(93)
Adult
(81)
Female
(78)
Aged
(72)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(44)
Pharmacology. Drug Treatments
(43)
Antineoplastic Agents
(40)
Prognosis
(40)
Chemotherapy
(36)
Tumors
(35)
Testicular Neoplasms - Pathology
(34)
Combined Modality Therapy
(27)
Follow-Up Studies
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy

Sexuality and body image in long-term survivors of testicular cancer

Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy – results of an exploratory phase I study

Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease

Chemotherapy-Induced Nausea, Vomiting, and Fatigue – the Role of Individual Differences Related to Sensory Perception and Autonomic Reactivity

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity

2599 Gemcitabine, Cisplatin, and Paclitaxel (GCT) as second-line salvage chemotherapy for germ cell tumors

Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma - results from a randomised phase II trial

Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group

Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial

A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Increasing international efforts to understand and conquer testicular germ cell cancer

Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)

Health-related quality of life (HRQOL) in the Nordic randomized trial of adjuvant intermediate-dose interferon alfa-2b in high-risk melanoma

Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma

Suchergebnisse filtern